Coronavirus Outbreak - The Singapore Story: The Development of a locally made diagnostic test kit for combatting the global COVID-19 pandemic. 

Register for webinar here: info.bio-rad.com/Coronavirus-Outbreak-The-Singapore-Story-Webinar.html

The COVID-19 virus that can cause severe respiratory complication has already infected more than 197,384 and killed more than 7,962 people worldwide. A key step to help address this urgent public health situation is the ability to quickly and accurately diagnose infected individuals to mitigate the spread of the virus.

As part of Singapore’s unwavering effort in curbing the widespread deadly COVID-19, A*STAR Fortitude Kit 2.0 is the first RT-PCR SARS-CoV-2 diagnostic test in Singapore that has been deployed as complete kits to the clinical community.

It was developed by researchers at Singapore’s Agency for Science, Technology and Research (A*STAR) and Tan Tock Seng Hospital (TTSH). The kit has been given Provisional Authorisation from the Health Sciences Authority (HSA), Singapore, for their intended use in Singapore.

Fortitude Kit 2.0 has been swiftly dispatched to both the Singapore public hospital networks as well as China to accurately screen thousands of patients for the coronavirus, reducing the wait time for results and allowing those infected to be treated timely.

Join this webinar to find out more on the recipe of success of the Singapore team in producing the Fortitude Kit 2.0 with high accuracy and performance within a short period of time, how the kit works and how RT-PCR enables SARS-CoV-2 detection.